API Name / End Use: Linagliptin (Intermediate – BBQ)
CAS Number: 853029-57-9
Molecular Formula: C20H17BrN6O2
Molecular Weight: 453.29 g/mol
Appearance: White to off-white crystalline powder
Storage: Store in a cool, dry place at room temperature (<25°C), protected from light and moisture
Chemox Pharma is a leading supplier and manufacturer of 8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione (CAS No.: 853029-57-9), commonly referred to as Linagliptin Intermediate – BBQ. This key intermediate is used in the synthesis of Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor widely prescribed for the treatment of type 2 diabetes mellitus.
As an ISO 9001:2015 certified company, Chemox Pharma ensures the supply of high-quality intermediates manufactured under strict global regulatory guidelines (DCGI, WHO-GMP, FDA). Each batch is produced with high purity, consistency, and complete documentation support to meet the requirements of international pharmaceutical companies.
With a strong focus on quality assurance, transparency, and compliance, Chemox Pharma is a trusted partner for global pharma industries. Our advanced R&D Centre enables process development, optimization, and cost-effective solutions, ensuring reliable supply and regulatory excellence.
Contact us today for sourcing Linagliptin Intermediate – BBQ (CAS No.: 853029-57-9) with competitive pricing, assured quality, and timely delivery.
| Sr. No. | Description | Application |
|---|---|---|
| 1 | Purine-based heterocyclic intermediate | API synthesis |
| 2 | Quinazoline-linked building block | Medicinal chemistry research |
| 3 | Advanced pharmaceutical intermediate | Drug discovery synthesis |
| 4 | Functional purine derivative | Specialty chemical manufacturing |
| 5 | Complex heterocyclic compound | Pharmaceutical R&D |
This compound is widely used in pharmaceutical research and development as a purine-quinazoline heterocyclic intermediate.
8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione should be handled according to standard pharmaceutical intermediate and laboratory chemical safety procedures. Proper industrial hygiene practices and protective measures must be followed during handling, processing, and synthesis operations.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of dust and contact with skin or eyes
Handle in controlled, well-ventilated environments
Follow chemical safety handling protocols
Refer to Safety Data Sheet (SDS) for detailed safety information
This compound is intended strictly for pharmaceutical intermediate and research use.
As a complex heterocyclic pharmaceutical intermediate, 8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione does not exhibit direct pharmacological activity. It functions as a structurally specialized purine-quinazoline building block in multi-step organic synthesis pathways for advanced active pharmaceutical ingredients. Its brominated purine core and quinazoline moiety enable selective substitution and coupling reactions essential in medicinal chemistry and drug development.
Handle in approved chemical or pharmaceutical facilities
Avoid exposure without protective equipment
Prevent dust generation and inhalation
Follow laboratory and industrial chemical safety procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain cool, dry storage conditions
Keep in designated chemical storage areas
Follow standard warehouse practices
It is a complex heterocyclic pharmaceutical intermediate used in advanced API synthesis, medicinal chemistry research, and drug discovery development.
Yes, Chemox Pharma manufactures and supplies 8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione (CAS 853029-57-9) with high purity for pharmaceutical research and synthesis applications.
It is a brominated purine-quinazoline heterocyclic intermediate used as a specialized building block in pharmaceutical and medicinal chemistry synthesis.
The CAS number is 853029-57-9.
It should be stored in tightly sealed containers in a cool, dry place protected from moisture and light, following standard chemical storage practices.
API Name / End Use: Olmesartan (Intermediate – OLMI-1) CAS Number: 144689-93-0 Molecular Formula: C12H20N2O3 Molecular Weight: 240.30 g/mol Appearance: White to
API Name / End Use: Olmesartan (Intermediate – DMDO-CL) CAS Number: 80841-78-7 Molecular Formula: C5H7ClO3 Molecular Weight: 150.56 g/mol Appearance: Clear to
API Name / End Use: Dapagliflozin (Intermediate) CAS Number: 461432-25-2-7 Molecular Formula: C28H31ClO10 Molecular Weight: 563.99 g/mol Appearance: White to off-white crystalline